In partnership with Insight, Orthoptics Australia (OA) is marking this year’s Orthoptics Awareness Week (31 May-4 June) with five articles, themed: ‘A day in the life of an orthoptist – through my eyes’. It features orthoptists who are advancing eye research and contributing to innovative models of care in various clinical settings across Australia.
The World Health Organisation defines a clinical trial as “a type of research that studies new tests and treatments and evaluates their effects on human health outcomes”. Clinical trials are integral for finding new and improved ways to treat, prevent or diagnose different types of illnesses.
Whether it’s digital marketing, succession planning or practice acquisition, an increasing number of independents are turning to Eyecare Plus to ensure the viability of their business in an ever-changing optometric landscape.
A new era in ophthalmic surgery has dawned with the emergence of 3D visualisation systems. Surgeons discuss how Alcon’s latest advance in this field is offering new levels of comfort, efficiency and teaching advantages in Australian operating theatres.
Orthoptist MADELAINE MOORE moved to the Northern Territory to escape the city limits. But on her way, she’s found fulfilment working to improve eye health outcomes for indigenous communities. Read more
As part of Macula Month this May, Insight examines drug development programs that could significantly alter the late-stage AMD therapy landscape. Leading experts also discuss why optometrists are such an important link in the success of both patient outcomes and clinical trials.
In the workshop well-established processes can be the difference between providing quality service or poor outcomes. It’s also an effective tool for training and development, writes Bruce Wain. Read more
Optos’s ultra-widefield imaging systems are renowned for some of the most superior views of the retina, but the company recently went a step further to incorporate swept source OCT. DR DAVID SIA from Pennington Eye Clinic – Australia’s first practice to have Silverstone installed – discusses why it’s so beneficial for vitreoretinal specialists, ocular oncologists and beyond.
Bausch + Lomb’s latest version of the enVista monofocal recently became available to Australian and New Zealand surgeons along with a new pre-loaded delivery system. Early adopters discuss making it a go-to IOL and how it’s offering increased depth-of-field in many patients.
Orthoptics Australia (OA) is marking its annual awareness week with a five-article series, featuring orthoptists who are advancing eye research and contributing to innovative models of care across the country. Read more